IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 242 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $288,014 | -98.4% | 29,908 | -98.2% | 0.00% | -97.4% |
| Q2 2023 | $17,960,458 | +79.6% | 1,688,013 | +77.5% | 0.04% | +56.0% |
| Q1 2023 | $10,001,743 | +629.0% | 950,736 | +699.1% | 0.02% | +525.0% |
| Q2 2022 | $1,372,000 | +319.6% | 118,980 | +275.7% | 0.00% | +33.3% |
| Q2 2020 | $327,000 | +153.5% | 31,670 | +147.7% | 0.00% | +50.0% |
| Q1 2020 | $129,000 | -43.2% | 12,787 | -38.4% | 0.00% | +100.0% |
| Q2 2019 | $227,000 | +29.7% | 20,747 | +60.5% | 0.00% | 0.0% |
| Q1 2019 | $175,000 | -42.2% | 12,926 | -55.7% | 0.00% | -50.0% |
| Q4 2018 | $303,000 | -9.0% | 29,207 | +67.7% | 0.00% | 0.0% |
| Q2 2018 | $333,000 | +57.8% | 17,412 | +27.4% | 0.00% | +100.0% |
| Q1 2018 | $211,000 | – | 13,672 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 16,390,000 | $172,422,800 | 22.05% |
| 13D Management LLC | 533,562 | $5,613,073 | 2.85% |
| Quantedge Capital Pte Ltd | 541,200 | $5,693,424 | 2.22% |
| Price Jennifer C. | 520,000 | $5,470,400 | 1.74% |
| Tamarack Advisers, LP | 210,000 | $2,209,200 | 0.81% |
| Intrinsic Value Partners, LLC | 51,605 | $542,885 | 0.73% |
| Brown Capital Management | 3,933,933 | $41,384,975 | 0.62% |
| Old West Investment Management, LLC | 75,219 | $791,303 | 0.43% |
| EMC Capital Management | 43,315 | $456 | 0.38% |
| Hillsdale Investment Management Inc. | 420,617 | $4,424,891 | 0.38% |